When doing open-heart surgery, the surgeon needs a still heart and lungs to work. The patient still needs oxygen circulated through the bloodstream to survive. Thus, cardiovascular perfusionists (also ...

The total number of patients enrolled across both parts is anticipated to exceed 650.

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

The MSc in Cardiovascular Perfusion provides a high-quality, research-led education that will equip you with enhanced knowledge, understanding and critical awareness of the current approaches and ...

TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.

NASHVILLE, Tenn.--(BUSINESS WIRE)-- SpecialtyCare, the largest and most experienced provider of clinical services to hospitals, announced today that is has completed the acquisition of Advanced ...

ORLANDO, FL — The investigational drug serelaxin (Novartis Pharmaceuticals), a recombinant form of the hormone relaxin-2 that has been tested primarily in acute decompensated heart failure (ADHF) with ...